NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IQV

IQVIA Holdings Inc

Jun 30 • 04:00PM ET

157.59

Dollar change +0.12
Percentage change 0.08	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: CROX MEDP LH ICON CTLT CRL INCY

| Held by: VTI VOO VO SPY IVV VTV VOT XLV IBB COWZ

Scroll to Statements

Index	S&P 500	P/E	21.48	EPS (ttm)	7.34	Insider Own	0.87%	Shs Outstand	174.10M	Perf Week	1.56%
Market Cap	27.26B	Forward P/E	12.16	EPS next Y	12.96	Insider Trans	0.08%	Shs Float	171.50M	Perf Month	11.75%
Enterprise Value	39.90B	PEG	2.46	EPS next Q	2.77	Inst Own	94.65%	Short Float	5.44%	Perf Quarter	-11.16%
Income	1.33B	P/S	1.76	EPS this Y	6.27%	Inst Trans	-3.61%	Short Ratio	3.78	Perf Half Y	-21.20%
Sales	15.50B	P/B	4.59	EPS next Y	9.56%	ROA	4.95%	Short Interest	9.33M	Perf YTD	-19.81%
Book/sh	34.33	P/C	14.53	EPS next 5Y	8.73%	ROE	21.65%	52W High	252.88 -37.68%	Perf Year	-25.38%
Cash/sh	10.84	P/FCF	12.60	EPS past 3/5Y	14.76% 50.90%	ROIC	6.93%	52W Low	134.65 17.04%	Perf 3Y	-25.50%
Dividend Est.	-	EV/EBITDA	11.78	Sales past 3/5Y	3.54% 6.79%	Gross Margin	27.52%	Volatility	2.34% 2.80%	Perf 5Y	12.43%
Dividend TTM	-	EV/Sales	2.57	EPS Y/Y TTM	-0.16%	Oper. Margin	14.66%	ATR (14)	4.35	Perf 10Y	116.71%
Dividend Ex-Date	-	Quick Ratio	0.82	Sales Y/Y TTM	2.84%	Profit Margin	8.61%	RSI (14)	57.86	Recom	1.54
Dividend Gr. 3/5Y	- -	Current Ratio	0.82	EPS Q/Q	-10.18%	SMA20	2.11%	Beta	1.31	Target Price	184.58
Payout	0.00%	Debt/Eq	2.43	Sales Q/Q	2.43%	SMA50	5.42%	Rel Volume	1.15	Prev Close	157.47
Employees	88000	LT Debt/Eq	2.22	Earnings	May 06 BMO	SMA200	-16.65%	Avg Volume	2.47M	Price	157.59
IPO	May 09, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.54% 1.49%	Trades		Volume	2,841,004	Change	0.08%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-25-25	Downgrade	HSBC Securities	Buy → Hold	$160
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight	$170
Feb-03-25	Downgrade	BTIG Research	Buy → Neutral
Dec-20-24	Initiated	Stephens	Overweight	$250
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform	$275
Jul-24-24	Downgrade	Jefferies	Buy → Hold	$266 → $242
Jun-06-24	Initiated	Goldman	Buy	$270
Feb-26-24	Initiated	Leerink Partners	Outperform	$290
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy	$285
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral	$248 → $202
Sep-06-23	Initiated	HSBC Securities	Buy	$260
Mar-17-23	Initiated	Truist	Buy	$265
Dec-06-22	Initiated	Cowen	Outperform	$251
Nov-17-22	Downgrade	Citigroup	Buy → Neutral	$275 → $245
Aug-25-22	Initiated	Credit Suisse	Outperform	$300
Jul-15-22	Initiated	SVB Leerink	Outperform	$256
May-24-22	Initiated	Guggenheim	Buy	$244
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight	$231 → $255

Show Previous Ratings

Today 12:39AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Jun-27-25 09:15AM	Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last? (Zacks)
Jun-26-25 06:01PM	The Top 5 Analyst Questions From IQVIA's Q1 Earnings Call (StockStory)
10:15AM	Trump Vows To Cut 'The Best Deal' On Drug Prices. What To Expect. (Investor's Business Daily)
Jun-17-25 10:18AM	AI Healthcare Funding Surges as Real-World Rollouts Hit Pharmacies, Hospitals, and Providers (PR Newswire)
11:34PM	Loading…
Jun-16-25 11:34PM	Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV) (StockStory)
09:00AM	IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for 'Best Mobile App for Patient Engagement' (Business Wire)
Jun-11-25 07:00AM	IQVIA Launches New AI Agents for Life Sciences and Healthcare (Business Wire)
Jun-05-25 11:44AM	Doximity Declines 4.4% in a Month: How to Play the Stock Now? (Zacks)
Jun-02-25 04:37PM	IQVIA Announces Pricing of Senior Notes (Business Wire)
08:10AM	IQVIA Announces Offering of Senior Notes (Business Wire)
May-31-25 03:00AM	Ipca Laboratories Ltd (BOM:524494) Q4 2025 Earnings Call Highlights: Strong Domestic Growth and ... (GuruFocus.com)
May-27-25 07:00AM	Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF (PR Newswire)
May-19-25 08:48AM	IQV Q1 Earnings Call: Real-World Evidence Drives Outperformance Amid Sector Uncertainty (StockStory)
05:40AM	IQVIA and SCRI partner to enhance oncology trials (Clinical Trials Arena)
08:00AM	Loading…
May-16-25 08:00AM	IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials (Business Wire)
May-14-25 04:54PM	S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal (Investopedia) -5.88%
May-13-25 09:16AM	Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends (Zacks)
May-07-25 06:03PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
04:15PM	IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13 (Business Wire)
03:12AM	IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
02:44AM	Q1 2025 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
May-06-25 09:00PM	IQVIA (IQV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
12:33PM	IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y (Zacks)
08:10AM	IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:10AM	IQVIA: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports First-Quarter 2025 Results (Business Wire)
May-05-25 03:05AM	After an up and down year, pharmas R&D landscape is shifting again (Pharma Voice)
May-01-25 09:34AM	IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock? (Zacks)
09:15AM	IQVIA (IQV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
10:01AM	Loading…
Apr-30-25 10:01AM	RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-29-25 10:01AM	IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-28-25 06:50PM	IQVIA Holdings Inc. (IQV): Among Billionaire Israel Englander's Stock Picks with Huge Upside Potential (Insider Monkey)
09:00AM	IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards (Business Wire)
Apr-27-25 11:40PM	Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results (Seeking Alpha)
Apr-25-25 09:18AM	HSBC shuffles MedTech stocks, cutting 4, upgrading 2 (Investing.com)
09:16AM	3 Healthcare Stocks That Concern Us (StockStory)
Apr-23-25 09:00AM	IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm (Business Wire)
02:38AM	Oakmark U.S. Concentrated Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-21-25 04:15PM	IQVIA to Announce First-Quarter 2025 Results on May 6, 2025 (Business Wire)
Apr-16-25 02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
12:30AM	Cedar Creek Partners Q1 2025 Results (Seeking Alpha)
Apr-15-25 08:00AM	Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report (Business Wire)
Apr-11-25 12:30PM	Oakmark Global Select Fund Q1 2025 Commentary (Seeking Alpha)
12:20PM	Oakmark Select Fund Q1 2025 Commentary (Seeking Alpha)
Apr-10-25 10:42AM	IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last? (Zacks) -8.79%
Apr-08-25 09:43AM	IQVIA Holdings Inc. (IQV): Among Stocks with Buy Ratings that Hedge Funds Love (Insider Monkey) -5.57%
Apr-01-25 02:27AM	Impax Global Social Leaders Fund Q4 2024 Commentary (Seeking Alpha)
Mar-31-25 03:15PM	Impax Large Cap Fund Q4 2024 Commentary (Seeking Alpha)
Mar-27-25 06:32PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Mar-26-25 10:59AM	Paychex Q3 Earnings & Revenues Surpass Estimates, Increase Y/Y (Zacks)
10:53AM	Here's Why Investors Must Hold IQV Stock in Their Portfolios Now (Zacks)
05:03AM	Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Mar-24-25 12:35PM	Why IQVIA Holdings Inc. (IQV) is Among the Best Diagnostics Stocks to Invest in Right Now (InsiderMonkey)
Mar-23-25 08:06PM	Tracking William Nygren's Harris Associates Portfolio - Q4 2024 Update (SeekingAlpha)
Mar-21-25 07:40AM	IQVIA Holdings (IQV) Fell on Lowered Guidance (InsiderMonkey)
Mar-20-25 02:50AM	Lazard Global Equity Select Portfolio Q4 2024 Commentary (SeekingAlpha)
Mar-19-25 05:09AM	3 Reasons IQV is Risky and 1 Stock to Buy Instead (StockStory)
Mar-10-25 09:00AM	IQVIA recognized as a leader in IDC MarketScapes 2024 assessment for decentralized clinical trial technologies and consulting services (Business Wire)
Mar-04-25 09:00AM	IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials (Business Wire)
Feb-25-25 09:40AM	IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Feb-24-25 09:00AM	IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence (Business Wire)
Feb-21-25 09:00AM	IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025 (Business Wire)
Feb-20-25 10:06AM	IQVIA Releases 2024 Sustainability Report (Business Wire)
Feb-14-25 09:15AM	IQVIA (IQV) International Revenue Performance Explored (Zacks)
Feb-12-25 08:03AM	West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-07-25 03:36PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
02:15AM	IQVIA Holdings Inc (IQV) Q4 2024 Earnings Call Highlights: Record Free Cash Flow and Strategic ... (GuruFocus.com)
02:08AM	Q4 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-06-25 09:30AM	Here's What Key Metrics Tell Us About IQVIA (IQV) Q4 Earnings (Zacks)
08:10AM	IQVIA Holdings (IQV) Beats Q4 Earnings and Revenue Estimates (Zacks)
08:08AM	IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars (StockStory)
07:17AM	IQVIA: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance (Business Wire)
Feb-05-25 08:10AM	IQVIA (IQV) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-04-25 11:00AM	IQVIA named to the Fortune Worlds Most Admired Companies list, ranked No. 1 in its sector for fourth consecutive year (Business Wire)
09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
Feb-03-25 09:50AM	IQVIA Holdings (IQV) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
09:16AM	Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics (Zacks)
Jan-30-25 03:55AM	IQVIA Holdings Inc. (IQV): Driving Healthcare Advancements with NVIDIA AI Collaboration (Insider Monkey)
Jan-21-25 04:15PM	IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025 (Business Wire)
Jan-17-25 09:50AM	Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock (Zacks)
Jan-16-25 09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
Jan-15-25 12:10PM	Will IQVIA (IQV) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:34AM	IQVIA Holdings (IQV) Fell Due to Reduced Near-Term Outlook in its R&D Solutions (Insider Monkey)
Jan-13-25 02:12PM	Why Tech Stocks Are Dropping Monday (Investopedia)
09:00AM	JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic (Pharmaceutical Technology)
09:00AM	IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions (Business Wire)
Dec-23-24 10:19AM	IQVIA (IQV) Surges 3.0%: Is This an Indication of Further Gains? (Zacks)
08:00AM	Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute (Business Wire)
Dec-14-24 09:00PM	The Drugs Young Bankers Use to Get Through the Dayand Night (The Wall Street Journal)
Dec-04-24 10:55AM	A 12-Year-Olds Journey Into the World of Ozempic (The Wall Street Journal)
Dec-03-24 12:41AM	Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China (The Wall Street Journal)
Nov-06-24 04:15PM	IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024 (Business Wire)
Nov-05-24 07:11AM	Iqvia price target lowered to $265 from $280 at Morgan Stanley (TipRanks)
Nov-04-24 09:15AM	Interpreting IQVIA (IQV) International Revenue Trends (Zacks)
Nov-01-24 02:27PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
03:10AM	IQVIA Holdings Inc (IQV) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges (GuruFocus.com)
01:04AM	Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight (GuruFocus.com)
12:45AM	Q3 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOUSBIB ARI	See Remarks	Feb 10 '25	Option Exercise	65.16	40,000	2,606,400	837,083	Feb 12 05:11 PM
DANHAKL JOHN G	Director	Dec 03 '24	Buy	200.58	1,275	255,740	1,275	Feb 07 07:03 PM
Sherbet Eric	See Remarks	Aug 27 '24	Sale	246.33	1,300	320,229	19,536	Aug 29 05:02 PM
Sherbet Eric	Officer	Aug 27 '24	Proposed Sale	246.33	1,300	320,229		Aug 27 05:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IQV

IQVIA Holdings Inc

Upgrade your FINVIZ experience